Takayanagi, Yoichiro
Ishizuka, Koko
Laursen, Thomas M.
Yukitake, Hiroshi
Yang, Kun
Cascella, Nicola G.
Ueda, Shuhei http://orcid.org/0000-0001-8107-8608
Sumitomo, Akiko
Narita, Zui
Horiuchi, Yasue http://orcid.org/0000-0003-0597-2514
Niwa, Minae
Taguchi, Akiko
White, Morris F.
Eaton, William W.
Mortensen, Preben B.
Sakurai, Takeshi
Sawa, Akira http://orcid.org/0000-0003-1401-3008
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH-105660, MH-094268 Silvio O. Conte center, MH-092443, MH-107730)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Maryland Stem Cell Research Fund
Stanley Foundation
Brain and Behavior Research Foundation
S-R/RUSK
Stanley Medical Research Institute
Kakenhi from the Ministry of Education, Culture, Sports, Science and Technology in Japan the Takeda and Kyoto University Basic and Clinical Research Project for CNS Drugs
Article History
Received: 1 July 2019
Revised: 5 October 2020
Accepted: 26 October 2020
First Online: 10 November 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.